Biotage AB (publ) publishes its 2016 Annual Report and Corporate Governance Report and Financial Goals for the period 2017 – 2019

Biotage’s 2016 Annual Report and Corporate Governance Report are as of today available at:  www.biotage.com

Biotage have two financial goals in its business, an organic growth goal of 8 percent and an EBIT-goal of 15 percent. The EBIT-goal used to be 10 percent but as a consequence of the beneficial development of the business, the EBIT-goal is now adjusted to 15 percent. The goals are formulated as an average for the three-year period 2017 – 2019.


This information is information that Biotage AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 08.30 CET on April 6, 2017.



About Biotage

Biotage offers efficient separation technologies from analysis to industrial scale and high quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by government authorities, academic institutions, pharmaceutical and food companies, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan and South Korea. Biotage has approx. 300 employees and had sales of 667 MSEK in 2016. Biotage is listed on the NASDAQ OMX Nordic. Website: www.biotage.com

Tags:

About Us

Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, separation and purification. The customers include pharmaceutical and biotech companies, companies within the food industry and leading academic institutes. The company is headquartered in Uppsala and has offices in the US, UK, China and Japan. Biotage has approx. 290 employees and had sales of 463 MSEK in 2012. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website: www.biotage.com